Literature DB >> 9072592

The International Continence Society "Benign Prostatic Hyperplasia" Study: the botherosomeness of urinary symptoms.

T J Peters1, J L Donovan, H E Kay, P Abrams, J J de la Rosette, D Porru, J W Thüroff.   

Abstract

PURPOSE: We assessed the bothersomeness of lower urinary tract symptoms as reported by men, and investigated relationships among occurrence, degree of problem caused and age.
MATERIALS AND METHODS: Questionnaire data from 1,271 men presenting with lower urinary tract symptoms in 12 countries were analyzed. Statistical methods included distributions, cross tabulations, chi-square analysis and Spearman's rank correlation coefficients.
RESULTS: Although prevalence and bothersomeness were moderately positively related, voiding symptoms were the most prevalent whereas the most bothersome were predominantly storage symptoms, including incontinence. While prevalence showed a broadly decreasing trend with age, bothersomeness was relatively unrelated to age.
CONCLUSIONS: These findings suggest that symptom occurrence alone does not necessarily reflect the degree to which patients are bothered by lower urinary tract symptoms. Therefore, when deciding on treatment it is important not only to consider the presence and frequency of lower urinary tract symptoms but also the bother that they cause.

Entities:  

Mesh:

Year:  1997        PMID: 9072592

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  45 in total

Review 1.  Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxin.

Authors:  Abdel-Rahmène Azzouzi; Marc Fourmarier; Francois Desgrandchamps; Charles Ballereau; Christian Saussine; Olivier Haillot; Bertrand Lukacs; Marian Devonec; Alexandre de la Taille
Journal:  World J Urol       Date:  2006-05-18       Impact factor: 4.226

Review 2.  Male overactive bladder: the role of urodynamics and anticholinergics.

Authors:  Scott MacDiarmid; Alexandra Rogers
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

Review 3.  [Medical combination therapy in LUTS suggestive of BPH].

Authors:  K Höfner; M Oelke
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

4.  Effect of transurethral resection of the prostate based on the degree of obstruction seen in urodynamic study.

Authors:  Dong Suk Min; Hee Ju Cho; Jung Yoon Kang; Tag Keun Yoo; Jeong Man Cho
Journal:  Korean J Urol       Date:  2013-12-10

5.  [Treatment for overactive bladder].

Authors:  P Rothe; M Kalchthaler; S Mühlich
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

6.  Effect of morphine on lower urinary tract discomfort after transurethral resection of prostate under general anesthesia: a randomised clinical study.

Authors:  Ferdi Menda; Sibel Temur; Sevgi Bilgen; Faruk Yencilek; Hakan Koyuncu; Nurcan Sancar; Ozge Koner
Journal:  J Anesth       Date:  2013-03-20       Impact factor: 2.078

7.  The Best of Both Worlds: An Example Mixed Methods Approach to Understand Men's Preferences for the Treatment of Lower Urinary Tract Symptoms.

Authors:  Divine Ikenwilo; Sebastian Heidenreich; Mandy Ryan; Colette Mankowski; Jameel Nazir; Verity Watson
Journal:  Patient       Date:  2018-02       Impact factor: 3.883

8.  Effects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study.

Authors:  Seung Hwan Lee; Seok Soo Byun; Seung Ju Lee; Khae Hawn Kim; Ji Youl Lee
Journal:  Int Urol Nephrol       Date:  2013-10-05       Impact factor: 2.370

9.  Development of a quality of life scale specific for patients with benign prostatic hyperplasia.

Authors:  Kamil Cam; Talha Muezzinoglu; Omer Aydemir; Recep Buyukalpelli; Gokhan Toktas; Hakan Gemalmaz
Journal:  Int Urol Nephrol       Date:  2013-02-19       Impact factor: 2.370

10.  Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction.

Authors:  Petros Sountoulides; Marleen M van Dijk; Hessel Wijkstra; Jean J M C H de la Rosette; Martin Christian Michel
Journal:  World J Urol       Date:  2009-10-09       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.